Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "I have two short sells - Ajanta Pharma had a big decline a couple of days ago and that decline seems to be continuing.""Ceat also had a large decline with a small trading range which can break on the downside," he said."I have one buy idea on Bata India which is outperforming and perhaps that outperformance can continue even after the Budget or even during the Budget."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
